News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

BioNTech and CEPI Announce Collaboration to Advance mRNA Mpox Vaccine Development and Bolster CEPI's '100 Days Mission

Tuesday, September 19, 2023

BioNTech SE Nasdaq BNTX and the Coalition for Epidemic Preparedness Innovations CEPI have announced a strategic partnership to advance the development of mRNAbased vaccine candidates focusing on the creation of BNT for the prevention of mpox

Orexo Submits New Drug Application to FDA for High-Dose Medication OX124 to Counter Opioid Overdose

Monday, September 18, 2023

Orexo AB publ which is publicly traded on the Stockholm Stock Exchange under the symbol STO ORX and on the OTCQX as ORXOY has officially submitted a New Drug Application NDA to the US Food and Drug Administration FDA for OX

Exmoor Pharma and Kincell Bio Announce Partnership to Offer Extensive Development and Manufacturing Services for Worldwide Cell and Gene Therapy Clients

Saturday, September 16, 2023

Exmoor Pharma and Kincell Bio have announced a new global partnership to offer a broad range of advanced therapy manufacturing services

Ascendis Pharma Granted Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) in Chronic Hypoparathyroidism Treatment for Adults

Friday, September 15, 2023

Ascendis Pharma AS Nasdaq ASND made an announcement today regarding a favorable development The Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency has issued a positive opinion and recommended approval for TransCon P...

Bionomics Shares Recent Developments in Collaboration with MSD for α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Research

Friday, September 15, 2023

Bionomics Limited Nasdaq BNOX a clinicalstage biotechnology company dedicated to developing innovative allosteric ion channel modulators for the treatment of severe central nervous system

MHRA Grants Approval to Rentschler Biopharma's Advanced Therapy Medicinal Product (ATMP) Facility in Stevenage, UK

Thursday, September 14, 2023

Rentschler Biopharma SE a leading global contract development and manufacturing organization CDMO specializing in biopharmaceuticals including advanced therapy medicinal products ATMPs has announced the receipt of the cGMP Manufacturing Compliance Ce...

Adaptive Launches Integration Between Clonoseq® and Epic

Thursday, September 14, 2023

Adaptive Biotechnologies Corporation Nasdaq ADPT is a biotechnology company with a focus on leveraging the genetics of the adaptive immune system for clinical applications The company recently announced the integration of its clonoSEQ test into Aura...

Dignify Therapeutics and Aayam Therapeutics Announce Licensing Agreement for a Novel on-demand Bowel Management Medication

Thursday, September 14, 2023

Dignify Therapeutics Dignify has recently announced a licensing agreement with Aayam Therapeutics Aayam aimed at developing compound ATX and related proprietary molecules to address ondemand defecation

US FDA Grants Orphan Drug Designation to CyGenica Limited for Innovative Glioblastoma Multiforme Treatment Drug Conjugate

Wednesday, September 13, 2023

GBM remains a formidable challenge in the field of oncology demanding innovative and effective treatment solutions CyGenicas Orphan Drug Designation approval for their unique drug conjugate underscores their commitment to addressing the unmet medical...

Pierre Fabre Laboratories Completes Acquisition of Vertical Bio, Advancing Novel Targeted Therapy for Non-Small Cell Lung Cancer Patients with MET Alterations

Wednesday, September 13, 2023

Pierre Fabre Laboratories the French pharmaceutical and dermocosmetic company has announced its acquisition of Vertical Bio AG a company specializing in the development of novel cancer therapies